Qube Research & Technologies (QRT)
CDLX icon

Qube Research & Technologies (QRT)’s Cardlytics CDLX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,176
Closed -$221K – 3580
2025
Q4 		$221K Buy
19,176
+16,924
+752% +$261K ﹤0.01% 3034
2025
Q3 		$54.7K Buy
+2,252
New +$37.5K ﹤0.01% 3170
2024
Q2 		– Sell
-1,216
Closed -$176K – 3879
2024
Q1 		$176K Sell
1,216
-700
-37% -$59.1K ﹤0.01% 3080
2023
Q4 		$176K Buy
+1,916
New +$195K ﹤0.01% 2849
2022
Q3 		– Sell
-2,424
Closed -$541K – 2543
2022
Q2 		$541K Buy
+2,424
New +$812K ﹤0.01% 1377
2021
Q2 		– Sell
-654
Closed -$718K – 2310
2021
Q1 		$718K Buy
+654
New +$864K 0.01% 985
2020
Q2 		– Sell
-636
Closed -$222K – 1730
2020
Q1 		$222K Buy
636
+193
+44% +$137K 0.01% 833
2019
Q4 		$279K Buy
+443
New +$217K 0.01% 1248

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CDLX Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Cardlytics (CDLX) in Q1 2026, closing a stake of 19,176 shares — an estimated $221K sold.

Qube Research & Technologies (QRT) first reported a position in CDLX in Q4 2019 and held it in 8 quarters. The position peaked at $718K in Q1 2021. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Cardlytics position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 19,176 Cardlytics shares in Q1 2026, an estimated $221K.
  • Qube Research & Technologies (QRT) first reported a position in Cardlytics in Q4 2019 and held it in 8 quarters.
  • Qube Research & Technologies (QRT)'s Cardlytics position peaked at $718K in Q1 2021.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.